AstraZeneca: Myocardial Infarction trials

The registry lists 20 Myocardial Infarction studies with AstraZeneca as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 1 1Phase 2 4Phase 3 3Phase 4 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.CompletedNCT04564742Phase 3Results posted
• Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction StudyCompletedNCT02406677Phase 4Results posted
• Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVRTerminatedNCT02227368Phase 2Results posted
• A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial InfarctionCompletedNCT01874262Not applicableResults posted
• A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)CompletedNCT01347580Phase 4Results posted
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinCompletedNCT01225562Phase 3Results posted
• A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCompletedNCT00642811Phase 2Results posted
• Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMITerminatedNCT00546260Phase 2Results posted
• A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With AspirinCompletedNCT00528411Phase 2Results posted
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary SyndromeCompletedNCT00391872Phase 3Results posted
• Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical PracticeCompletedNCT04568083
• ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in MoscowCompletedNCT03654157
• Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical RegistryCompletedNCT02271022
• A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for AtherothrombosisCompletedNCT01984307
• Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI PatientsTerminatedNCT01866904
• Metoprolol in Acute Myocardial Infarction. A PK/PD StudyCompletedNCT01523054Phase 1
• Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease DeathCompletedNCT01360073
• Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary DeathCompletedNCT01360047
• Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After DischargeCompletedNCT01171404
• Statins and Risk of Myocardial Infarction in Real Life in FranceCompletedNCT00679575